Product Description
COL1A1 mRNA-loaded Evs. (Sourced from: https://classic.clinicaltrials.gov/ct2/show/NCT06438341)
Mechanisms of Action: Collagen Inducer
Novel Mechanism: Yes
Modality: Nucleic Acid
Route of Administration: Subcutaneous
FDA Designation: None *
Approval Status: Not Approved
Approved Countries: None
Approved Indications: None
Known Adverse Events: None
Company: SIPO Biotechnology Co. Ltd.
Company Location:
Company CEO:
Additonal Commercial Interests: None
Clinical Description
![Map of Global Clinical Trials for SPOT-mRNA01](https://pryzm-maps.s3.us-west-2.amazonaws.com/666666current_maps.png)
Countries in Clinic: